- Medical - Diagnostics & Research
- Healthcare
IDEXX Laboratories, Inc.
IDXX · US ·
NASDAQ
468.63
USD
-9.21
(1.97%)
-
10.43
EPS
-
44.94
P/E
-
38.7B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 10.6 | 11.1 | 13.2 | 15.1 | 16.7 | 19.2 | 12.73% |
| Avg. Estimate | 10.4 | 11.1 | 12.5 | 14.3 | 16.5 | 19 | 12.73% |
| Low Estimate | 10.3 | 11 | 11.7 | 13 | 16.3 | 18.7 | 12.73% |
| No. Of Analysts | 8 | 9 | 10 | 8 | 5 | 6 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 3.74B | 3.96B | 4.36B | 4.79B | 5.28B | 5.85B | 9.38% |
| Avg. Estimate | 3.72B | 3.94B | 4.32B | 4.75B | 5.24B | 5.79B | 9.24% |
| Low Estimate | 3.71B | 3.92B | 4.28B | 4.7B | 5.18B | 5.74B | 9.08% |
| No. Of Analysts | 8 | 8 | 9 | 9 | 8 | 3 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 1.04B | 936M | 1.11B | 1.27B | 1.4B | 1.61B | 9.18% |
| Avg. Estimate | 867M | 930M | 1.04B | 1.16B | 1.39B | 1.59B | 12.97% |
| Low Estimate | 693M | 926M | 984M | 1.09B | 1.37B | 1.57B | 17.82% |
| No. Of Analysts | 8 | 8 | 9 | 9 | 8 | 3 |